Skip to content

Clinical trials

Phase 1 Carcinoma, Non-Small-Cell Lung trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1 Country / region: New Zealand Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20161
20171
20181
20191
20202
20212
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated3
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Checkpoint Therapeutics, Inc.2
Genentech, Inc.2
AstraZeneca1
BeOne Medicines1
BeiGene1
Exelixis1
Hoffmann-La Roche1
Merck Sharp & Dohme LLC1
OncoMed Pharmaceuticals, Inc.1
RayzeBio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung12
Carcinoma, Transitional Cell4
Neoplasms4
Colorectal Neoplasms3
Lung Neoplasms3
Carcinoma, Renal Cell2
Melanoma2
Neoplasm Metastasis2
Small Cell Lung Carcinoma2
Squamous Cell Carcinoma of Head and Neck2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.